University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 3L-09-1


 
Description: GIDEON: Global Investigation of Therapeutic Decisions in Hepatocelluar Carcinoma and of its Treatment with Sorafenib.
Status: Open
Randomized? No


Researchers  
Principal InvestigatorTitle
Anthony El-KhoueiryM.D.

Data Management
NameTitle
Ramona LujanR.N.
Lynette SebastianD.M.
Yordy BritoD.M.
Carol JonesR.N.


You may participate in this study if:
 Requirement
1Outpatients with Histologically or cytologically documented or radiographically diagnosed unresectable hepatocellular carcinoma who are candidates for systemic therapy and for whom a decision to treat with Nexavar® has been made.
2Patients must have a life expectancy of at least 8 weeks
3Patients must have signed an informed consent form


You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.